Material innovation represents a cornerstone of advancement within the US 3D Bioprinting Market, with living cells and hydrogels serving as the primary drivers of technological capability and clinical utility. Living cells constitute the largest material segment by market share, reflecting the industry's fundamental commitment to creating biologically active tissues rather than inert scaffolds. The incorporation of patient-derived or allogeneic cells into bioinks enables the fabrication of immunocompatible tissues that can integrate with host physiology, perform metabolic functions, and respond to biological signaling pathways.

The dominance of living cell-based materials is inextricably linked to the rise of personalized medicine. Autologous cell sourcing, where a patient's own cells are expanded and incorporated into bioinks, eliminates immune rejection risks and enhances therapeutic outcomes. Advances in induced pluripotent stem cell technology have dramatically expanded the available cell types for bioprinting, allowing researchers to generate patient-specific cardiomyocytes, hepatocytes, and neural tissues from readily accessible somatic cells. These capabilities are transforming bioprinting from a scaffold-fabrication tool into a genuine tissue engineering platform capable of producing functional biological systems.

Hydrogels represent the second major material category and are experiencing significant growth due to their exceptional biocompatibility and tunable mechanical properties. Valued at $241.08 million in 2024, the hydrogels segment benefits from materials that can mimic the natural extracellular matrix, providing cells with appropriate biochemical cues and physical support. Alginate, gelatin, hyaluronic acid, and synthetic polyethylene glycol-based hydrogels each offer distinct advantages in terms of printability, degradation rates, and biofunctionalization potential.

The convergence of living cells and advanced hydrogels is yielding composite bioinks that combine the biological activity of cellular components with the structural integrity of polymer networks. These next-generation materials enable the fabrication of tissues with spatially graded properties, vascular channels, and embedded signaling molecules. As material science continues to advance, the development of stimuli-responsive, self-healing, and conductive bioinks will further expand the therapeutic possibilities of bioprinting, solidifying the material segment as a critical value driver in the US market.